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The Human Papillomavirus (HPV) belongs to the Papillomaviridae family and has a capsid and 
a single DNA strand. Its infection occurs mainly through sexual intercourse, having an important 
tropism for skin and mucosal cells.
Aim: To evaluate the HPV presence in normal oral mucosa of asymptomatic subjects and; in parallel, 
to correlate social behavioral habits with the virus.
Materials and Methods: Contemporary cohort cross-sectional study. The HPV was found by PCR, 
using general primers MY09/11 in 125 oral mucosa samples submitted to DNA extraction and PCR 
to search for the beta-globin gene in order to assess the quality of the extracted DNA. In parallel, 
we carried out a study of behavioral issues associated with the patients.
Results: All the samples had a positive diagnosis of the beta-hemoglobin gene. HPV was diagnosed 
in 23.2% of the samples analyzed.
Conclusion: The virus was present in 29 of the 125 patients, without them having any clinical-
pathological manifestation associated with the HPV. As to the social behavior of the patients, we 
concluded that oral sex is statistically correlated to the virus, and besides the HPV has been statistically 
more present in female patients.
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INTRODUCTION
The human papillomavirus (HPV) belongs to the 
Papillomaviridae family. They are small, epitheliotropic and 
have about 55 mm in diameter. Their genome is made up 
of 7,200 to 8,000 base pairs with molecular weights of 5.2 
x 106 daltons. The HPV is made up of a capsid with 72 
capsomeres of icosahedral structures, with a lipoprotein 
envelope and one single circular double DNA molecule1. 
Its genome is divided into E (Early - coding the proteins 
which are initially produced) and L (Late - codes proteins 
which will be produced after those from the E region). 
These two regions represent 45% and 40% of the viral 
genome, respectively, and have the open reading frames 
(ORFS) E1, E2, E4, E5, E6, E7, L1 and L2. It is known 
that the E1 gene is involved in viral DNA replication and 
maintenance; E2 regulates viral transcription and E4 codes 
a protein which destroys cytoplasmic keratin, producing 
the koilocytosis halo image. It is believed that E5, E6 and 
E7 are involved in cell transformation and degradation, 
while L1 and L2 code the viral capsid proteins. Between 
the E and L regions, there is the non-coding region called 
LCR (long control region) or URR (upstream regulatory 
region), representing 15% of the viral genome involved 
in the control of viral gene expression2.
HPV infection is basically through sexual inter-
course. As such, both men and women are involved 
in the epidemiological chain of the infection and are 
capable, at the same time, of being asymptomatic car-
riers, transmitters and victims of HPV infections. In these 
regards, the risk factors are clearly associated with the 
individual’s sexual behavior. The most important are: 
starting sexual intercourse at an early age, having a large 
number of sexual partners during one’s life and having 
sexual contact with high-risk individuals (i.e. men having 
frequent contact with female prostitutes; in the case of 
women, having intercourse with men who have multiple 
sexual partners)3.
HPV infects epithelial and mucosal cells, 
which can cause a number of hyperplastic lesions. 
Therefore, this virus can be mucosotropic, which infect 
the oral, respiratory and genital mucosae; and cutane-
otropic, found in immune-competent individuals and 
in those with verruciform epidermoplasias4. Since the 
HPV infects only the epithelial layer, not going beyond 
the basal membrane, the primary immune exposure 
must happen by means of mechanisms present in this 
layer. The infected cell membrane expresses only the E5 
protein, and this small quantity of surface viral antigens 
may damp the immune response. E5 binds and inactivates 
the protein that is needed to process the antigens. Since 
the epithelial cell is not a good antigen-presenting cell, 
the HPV remains inside it without being recognized by 
the immune system. Because the HPV does not cause 
host cell lysis or death, the virus remains isolated from 
contact with immune system cells, which would trigger 
the recognition process5.
The viral infection may cause localized clinical, 
subclinical or latent lesions. In general, the HPV follows 
the classic viral productive cycle: adsorption, penetration, 
transcription, translation, DNA replication and matura-
tion. However, in some cases, such process does not 
happen in a complete way, since the virus may integrate 
the genome of the host cell and cause carcinogenesis. 
In benign lesions, the virus is in its circular form, called 
episomal - not integrated to the host cell genome, and 
in a large number of copies. In malignant lesions, it is 
integrated to the host cell genome. Notwithstanding, it 
is possible to find episomal forms in the malignant cells 
and, once integrated, the virus cannot be reverted to its 
episomal form6.
Viral types of high and low malignance risks di-
fferentiate according to the transformation capacity of 
E6 and E7 oncoproteins, coded by genes E6 and E7. E6 
and E7 oncoproteins bind to p53 and pRB proteins, res-
pectively, regulators of the cell cycle, considered cancer 
suppression. This phenomenon unblocks the cell cycle 
and causes genetic instability, which causes additional 
genetic changes, causing cancer by preventing apopto-
sis, leading to cell immortalization. This process is found 
only in high risk virus, and it is not seen in their low risk 
counterparts7.
It is estimated that in Brazil there are from 500 
thousand to 1 million new cases per year of HPV infection, 
while 80 thousand cases of AIDS, 200 thousand to 500 
thousand cases of herpes, 100 thousand cases of syphilis 
and 800 thousand cases of gonorrhea are registered8. The 
presence of anogenital HPV 6/11 and 16/18 in the oral 
mucosa could mean orogenital transmission, which would 
make this virus an important cofactor in the development 
of oral cancer, as it is considered in the uterine cervix9. 
The HPV prevalence in the oral mucosa, macroscopically 
normal, varies substantially in the literature: between 0 to 
81.1%, with a mean of 10%. The infections are not always 
seen macroscopically. Thus, the HPV infection may be 
classified into: (a) latent, which may only be diagnosed 
by means of molecular biology assays; (b) subclinical, 
which does not bear clinical symptoms, but there are 
subtle changes which can be detected by diagnostic me-
thods such as peniscopy, colpocytology, colposcopy and/
or biopsy; (c) clinical, in which there are evident lesions 
upon clinical exam. From the molecular viewpoint, it is not 
known how an HPV infection remains latent, and anther 
develops macroscopic lesion of intense viral replication10. 
Progresses in the field of molecular biology and genetics 
have contributed substantially to study these viruses. Of 
all HPV DNA detection techniques, the polymerase chain 
reaction (PCR) is the most sensitive11.
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The human papillomavirus (HPV) stands out as one 
of the most common sexually transmitted diseases (STD) 
in the world. Every year, the Brazilian Health Department 
registers 137 thousand new cases in the country. Since 
the viral diagnosis can be made still in the latent phase 
of the infection, it is possible to follow the patient up in 
order to educate him/her about proper treatment for the 
lesions or alterations which may arise because of the viral 
infection progression. Thus, our study aims at establishing 
the HPV prevalence in the oral mucosa of patients who 
do not have any type of lesion and, concurrently, assess 
whether sexual and social habits, such as sexual activity, 
having a fixed partner, intercourse with prostitutes, oral 
sex practice, use of condoms and smoking, are associated 
with the virus.
MATERIALS AND METHODS
This study has been previously submitted to the 
appreciation and approval of the Ethics in Research Com-
mittee of the Institution, under protocol number: 840/2007.
Sample Selection
We randomly col lec ted 125 samples of 
oral mucosa swabs, from men and women, whom were 
told about the study, filled out the questionnaire with 
behavioral questions and signed the informed consent 
form, accepting to participate in the study. For sample 
collection purposes, we used the “Campos da paz” brush 
and the material was stored in Eppendorf®, tubes with 
0.9% saline. They were then frozen for preservation until 
the extraction.
Behavioral Questionnaire
The behavioral questionnaire was administrated 
after prior explanation about its importance in the study 
and that its data would be treated with the uttermost con-
fidentiality (Chart 1).
Statistical Analysis
The Fisher’s exact test was used as statistical tool 
in order to check whether the HPV prevalence would be 
statistically associated to sex and the patients’ life habits. 
A p-value below 0.05 proves correlation. We also obtai-
ned confidence interval (CI) values, set at 95% and Odds 
Ratio. Statistical data were produced by the SISA® (Simple 
Interactive Statistical Analysis) software.
DNA Extraction
Initially, we stirred the samples in vortex (AP56 
- Phoenix - Brazil), followed of the removal of 300 µl 
parts, which were transferred to another container. It was 
centrifuged and the supernatant was discarded. To the 
precipitate we added 600 µl of sodium hydroxide (NaOH) 
at 50 mM. We took it to hot water bath (MA159 - Marconi 
Chart 1. Regarding the Behavioral Questionnaire.
Behavioral questionnaire
ID number:__________
Skin color:__________
Age:__ Gender: (_) F or (_) M
Marital Status: __________
Occupation: Program: __________
Has already had sex? (_) Yes (_) No
Age of the first sexual intercourse:__________
Fixed partners: (_) Yes (_)No
Number of partners during 1 year:
(_) 1 to 3 (_) 4 to 7 (_) 10 or more
Have you had sexual intercourse with prostitutes?
Yes (_) No (_)
Do you practice Oral Sex: (_) Yes (_) No
Do you use condoms: (_) Yes (_) No
How often do you use condoms:
(_) in all intercourses (_) Sometimes (_) Never
Do you have, or have you had lesions in your mouth: (_) Yes (_) No
Frequency: (_) Frequently (_) Occasionally (_) Rarely
Do you have Herpes or HPV?: (_) Yes (_) No (_) Unknown
Does your partner have Herpes or HPV? (_) Yes (_) No (_) Unknown
Have you ever had any STD?__________
Smoker (_) Yes (_) No
Do you use medications (immune suppressors)? (_) Yes (_) No
- Brazil) at 95°C for 5 minutes and immediately after we 
added 60 µl of 1 M tris-HCL. The material extracted was 
frozen.
Polymerase Chain Reaction (PCR)
All the samples were submitted to PCR, using 
beta-globin to test the extraction method and avoid false 
negatives, since this gene is common to all human beings, 
thus showing up in all the samples.
To prepare the PCR mix for beta-globin, we used 1.5 
mL of Eppendorf®. The reaction mix was made up of: 12.5 
µl of deionized and autoclaved water, 2.5 µl of reaction 
buffer (10x - Invitrogen®), 1.0 µl of MgCl
2
 (50 mM - Invi-
trogen®), 2.5 µl of dNTP (deoxynucleoside triphosphate) 
solution (2 mM - Invitrogen®), 1.0 µl of the pair of primers12 
GH
2
0 (GAAGAGCCAAGGACAGGTAC)/PC04 (CAACTT-
CATCCACGTTCACC) at 10 pmol/µl (Invitrogen®), 4 µl of 
DNA and 0.5 µl of Taq polymerase (5U/µl - Invitrogen®), 
respectively, making up a total volume of 25 µl. In all 
amplified lots, we used negative controls (4 µl of water 
instead of DNA) and positive controls to detect possible 
contaminants during the reaction.
In order to prepare the PCR reaction mix for the 
HPV, we used 1.5 mL of Eppendorf®. The reaction mix is, 
respectively, made up of: 12.0 µl of autoclaved and deio-
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nized water, 2.5 µl of reaction buffer (10x - Invitrogen®), 
1.5µl of MgCl
2
 (50mM - Invitrogen®), 2.5 µl of dNTP (deo-
xynucleoside triphosphate) solution (2 mM - Invitrogen®), 
1.0µl pair of general primer 2 for HPV MY09 (GT CCM AAR 
GGA WAC TGA TC*)/MY11 (GCM CAG GGW CAT AAY 
AAT GG*) at 10 pmol/µl (Invitrogen®), 4 µl of DNA and 
0.5 µl of Taq polymerase (5U/µl - Invitrogen®), making up 
a total volume of 25 µl. In all the analyses we used nega-
tive controls (4 µl of water instead of DNA) and positive 
controls to detect contaminations and act as patterns of 
viral presence.
Thermal cycles for the PCR reactions were car-
ried out at the Peltier Thermal Cycler® (Biocycler Ther-
malcyclers), and the beta-globin amplification program 
was made up of: one initial cycle at 95°C for 5 minutes, 
35 sequential cycles made up of three stages (denaturation 
at 94°C for 1 minute, hybridization at 60°C for 1 minute 
and synthesis at 72°C for 1 minute) and a final cycle at 
72°C for 10 minutes. The PCR execution program for the 
general HPV primer was made up of: one initial cycle at 
95°C for 5 minutes, 35 sequential cycles made up of three 
stages (denaturation at 94°C for 1 minute, hybridization 
at 40°C for 1 minute and synthesis at 72°C for 1 minute) 
and one final cycle at 72°C for 10 minutes.
The PCR products were submitted to electropho-
resis in 1.5% agarose gel (0.75 g of agarose in 50 ml of 
TBE 1x and 5.0 µl of ethidium bromide buffer in a ho-
rizontal dish (Horizon 11-14® - Lifetechnologies - USA) 
under a potential difference of 100 volts during one 
hour. The gel was analyzed in a photo-Prep® transilumi-
nator, at which 268 pb bands were considered positive 
for beta-globin. For the product arising from the ampli-
fication with the general primer for HPV, we utilized 
the 10% Bis-acrylamide gel electrophoresis technique 
(23.33 ml of Bis-Acrylamide; 4.9 ml of Glycerol; 7 ml of 
TBE 10x; 52.5 µl of Temed; 1050 µl of potassium persul-
phate and 34.1 ml of distilled water), which was taken to 
a potential difference of 120 volts for 3 hours in a vertical 
dish (Model V15-17® - Lifetechnologies - USA) and the gel 
dyed by the silver nitrate protocol13, in order to visualize 
the bands.
RESULTS
We found viral DNA in 23.2% (29/125) of the sam-
ples, and they were all positive for the beta-globin ampli-
fication gene, guaranteeing reliability to the experiment. 
As to the behavioral questionnaire, among the variables 
studied (Gender, Sexual Activity, Fixed Partner, Sexual 
Intercourse with Prostitutes, Oral Sex, Condom Use and 
Smoking), it was only the patient gender (OR = 2.2404, CI 
[0.9339 - 5.3749], p = 0.03631) and having oral sex (OR = 
0.0473, CI [0.0095 - 0.2358], p = 0.0473) were statistically 
correlated with HPV (Figure 1).
Figure 1. Fischer’s Exact Test. (Statistically significant association 
when p < 0.05).
Among the individuals investigated in the study, 37 
(29.6%) volunteers were men, in the age range of 17-54 
years and 88 (70.4%) were women, in the age range of 
17-44 years. The age range between 18-21 predominated 
in both genders. Of the 29 positive HPV samples, 41.4% 
(12/29) were men and 58.6% (17/29) were women; 17.24% 
(5/29) were smokers; 24.13% (7/29) said they did not use 
condoms in all their sexual intercourses; 68.96% (20/29) 
stated they practiced oral sex; 13.79% (4/29) had not star-
ted their sexual life; 44.82% (13/29) did not have fixed 
partners, and 13.79% (4/29) had had sexual intercourse 
with prostitutes.
DISCUSSION
The literature describes numerous cytopathic effects 
associated with HPV infection (koilocytosis, nucleus wide-
ning, megalocytosis, binucleation, and others), as well as 
intraepithelial lesions, which vary from low grade (LSIL) 
to high grade (HSIL), which may progress to squamous 
cell carcinoma (SCC)14. Notwithstanding, HPV may be 
asymptomatic - given that most infections are subclinical 
or latent. According to Xavier et al.10, the HPV prevalence 
in a macroscopically normal oral mucosa is very much 
variable in the literature: it varies between 0 and 81.1%, 
with a mean value of 10%. Castro & Bussoloti15 stated 
that detection rates may vary between 0 and 100%, even 
when using a more sensitive method, such as PCR, and 
mention that this large discrepancy in results may be 
caused by errors at the time of material harvesting, which 
may compromise the final results. In a larger proportion, 
when compared to our results, Peixoto5 had 100 patients 
without oral mucosa lesion in his cohort and diagnosed 
81% viral prevalence; although, differently from our study, 
he did not find statistically significant association between 
having oral sex and HPV. Nonetheless, in agreement with 
our results, Cardesa & Nadal16 reported that oral sex is one 
of the main risk factors for the progression of the disease 
caused by the HPV. In regards to smoking and sex, Gilison 
et al.17 reported that HPV was more prevalent in men and 
smokers - their finding was statistically relevant, and they 
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also reported a 6.9% prevalence of HPV in the general 
population of the United States of America - when they 
assessed a cohort with 5,579 individuals without prior se-
lection. Kreimer et al.18, analyzed 1,688 samples from oral 
mucosae of healthy men - in agreement with our study - 
and did not find statistically significant association between 
the number of sex partners, use of condoms, as well as 
sexual activity and HPV in the oral mucosa. According to 
Castellsagué3, the use of condoms is a factor which may 
reduce the risks of HPV transmission; however, it does 
not guarantee total protection.
CONCLUSIONS
The human papillomavirus could be found in 23.2% 
of the 125 cases studied. Since these patients do not bear 
any clinical-pathological manifestation associated with the 
virus, the HPV may be present in healthy oral mucosae in 
significant proportions. Although American cohort studies 
have reported higher HPV prevalence in the oral mucosae 
of men - among the patients included in the study, the 
women and/or those who have oral sex made up the risk 
group in which HPV was statistically more prevalent.
Although other life habits did not reach statistical 
significance, studies with more patients must be carried 
out, since factors such as smoking, not using condoms, 
having multiple sex partners and sexual activity are fac-
tors which increase the likelihood of transmission and/or 
infection by the HPV.
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